FDA Commissioner, Dr. Scott Gottlieb and NIH Director, Dr. Francis Collins have responded to a letter from Sen. Brian Schatz requesting information about psychedelic drugs.
Oakland activists arrange May 28 meeting with the city council to discuss decriminalizing entheogens.
Newly-released "Final Unofficial" election results from the City of Denver show a 50.56% lead in Yes votes to decriminalize psilocybin mushrooms.
The vote was held to decide whether the city would deprioritize enforcement of psilocybin mushroom offenses.
Denverites head to the polls on May 7, 2019, to decide whether to deprioritize enforcement of psilocybin mushroom penalties.
"You have to start somewhere. These issues are important. When you introduce legislation, people start taking it more seriously."
Researchers push to move psilocybin from Schedule I to Schedule IV if Phase III clinical trials are successful.
The FDA will work to expedite the development and review of the drug so it can get to patients as soon as possible.